SAMRATPH - Analysis

Samrat Pharmachem Limited is engaged in the production of pharmaceutical chemicals like Iodine salts and Bromine salts. The Company's finished products are used in various industries, including pharmaceuticals, chemicals, food, fertilizer and salt.

Financials:
TTM EPS: 53.83
TTM PE: 7.25
P/B; 1.91
Face Value: 10
Mkt Cap (Rs. Cr.): 120
Dividend Yield: 0.26
Sector PE: 43.66
Book Value Per Share: 204.37

Positives:

1. Company with Low Debt
   
2. Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
   
3. Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
   
4. Book Value per share Improving for last 2 years
   
5. Company with Zero Promoter Pledge
   

Negatives:

1. Decline in Net Profit with falling Profit Margin (QoQ)
   
2. Decline in Quarterly Net Profit with falling Profit Margin (YoY)
   
3. Declining profits every quarter for the past 3 quarters
   
4. Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
   
5. Weak Momentum: Price below Short, Medium and Long Term Averages
   

Opinion: It has TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE. Can it reverse from this support zone ?

NOT A RECOMMENDATION. JUST FOR EDUCATION. Thanks.

Transaction en cours:

CMP 405.

Transaction en cours:

CMP 430